MicroRNA Isoforms Contribution to Melanoma Pathogenesis

Elisabetta Broseghini1, Emi Dika1,2, Eric Londin3

  • 1Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40126 Bologna, Italy.

Non-Coding RNA
|October 26, 2021
PubMed

Insights

MicroRNA variants called isomiRs are dysregulated in melanoma compared to benign nevi. This finding reveals specific isomiR patterns in cutaneous melanoma (CM) progression and metastasis.

Area of Science:

  • Molecular biology
  • Cancer research
  • Genomics

Background:

  • Cutaneous melanoma (CM) is an aggressive skin cancer with increasing incidence.
  • MicroRNAs (miRNAs) are crucial in melanoma pathogenesis.
  • MicroRNA isoforms (isomiRs) represent a new layer of regulatory complexity.

Purpose of the Study:

  • To comprehensively characterize miRNA and isomiR dysregulation in benign nevi (BN) and early-stage melanomas.
  • To analyze isomiR expression in primary melanoma versus metastasis using The Cancer Genome Atlas (TCGA) data.
  • To investigate the association of isomiR expression with NF1, BRAF, and NRAS mutations in melanoma.

Main Methods:

  • Analysis of next-generation sequencing (NGS) data for small-RNA expression.
  • Comparison of isomiR profiles between benign nevi and cutaneous melanoma.
  • Utilized The Cancer Genome Atlas (TCGA) dataset for melanoma metastasis analysis.

Main Results:

  • Benign nevi and melanoma exhibit distinct and specific isomiR expression profiles and abundance distributions.
  • IsomiRs derived from the same miRNA can display opposing expression trends between benign nevi and melanoma.
  • Differential expression of isomiRs was identified in primary melanoma and metastasis, with associations to specific mutations.

Conclusions:

  • Specific isomiRs are non-randomly dysregulated in cutaneous melanoma, contributing to disease pathogenesis.
  • IsomiR profiling offers insights into the complex molecular landscape of melanoma.
  • Identified isomiRs serve as potential biomarkers for further functional investigation and clinical application.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.6K